Ruximonab 500 mg Injection 50 ml is used in the treatment of Non-Hodgkin&#039;s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris. The detailed uses of Ruximonab 500 mg Injection 50 ml are as follows:&lt;br/&gt;&bull; Non-Hodgkin&rsquo;s Lymphoma (NHL): Ruximonab 500 mg Injection 50 ml is used to treat Non-Hodgkin&rsquo;s Lymphoma alone or with chemotherapy.&lt;br/&gt;&bull; Chronic Lymphocytic Leukemia (CLL): Ruximonab 500 mg Injection 50 ml is used in the treatment of Chronic Lymphocytic Leukemia (CLL) and B-cell Acute Lymphoblastic Leukemia (B-ALL.&lt;br/&gt;&bull; Rheumatoid Arthritis (RA): Ruximonab 500 mg Injection 50 ml is used in the treatment of rheumatoid arthritis.&lt;br/&gt;&bull; Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA): Ruximonab 500 mg Injection 50 ml helps to treat Granulomatosis with Polyangiitis and Microscopic Polyangiitis.&lt;br/&gt;&bull; Pemphigus Vulgaris: Ruximonab 500 mg Injection 50 ml is used to treat pemphigus vulgaris for moderate to severe cases.&lt;br/&gt;

Medicinal Benefits:

Ruximonab 500 mg Injection 50 ml contains Rituximab, which belongs to the class of monoclonal antibodies. It works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth. This helps prevent the growth and further spread of cancerous or non-cancerous cells. On the other hand, Ruximonab 500 mg Injection 50 ml works by interfering with the immune system process that causes inflammation in the joint tissues. Thus, it reduces pain and inflammation and prevents joint damage and disease progression over time.

FAQs

What is the use of Ruximonab 500 mg Injection 50 ml?

Ruximonab 500 mg Injection 50 ml is used to treat Non-Hodgkinâ€™s disease, rheumatoid arthritis, chronic lymphocytic leukaemia, granulomatosis and pemphigus vulgaris.

How does Ruximonab 500 mg Injection 50 ml work?

Ruximonab 500 mg Injection 50 ml contains Rituximab, which works by inhibiting the DNA and RNA transcription that is essential for cancer cell growth.

What are the conditions to be noted while receiving Ruximonab 500 mg Injection 50 ml?

Ruximonab 500 mg Injection 50 ml may cause bowel obstruction and perforation, reactivation of Hepatitis B infection, Cardiac arrhythmias, tumour lysis syndrome, and angina in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.

What is the composition of Ruximonab 500 mg Injection 50 ml?

Ruximonab 500 mg Injection 50 ml contains the active substance rituximab. This is a type of protein called a monoclonal antibody.

What are the side effects of Ruximonab 500 mg Injection 50 ml?

The common side effects of Ruximonab 500 mg Injection 50 ml are pale skin, painful urination, night sweats, flushing, back pain, nausea, vomiting, diarrhoea, stomach pain, mouth sores, peeling of skin, injection site reactions and pain at the site of injection. If any of these side effects persist or worsen, please consult your doctor.